The Georgetown Lombardi Comprehensive Cancer Center is home to an innovative Interdisciplinary Lung Cancer Clinic dedicated to the evaluation and management of lung cancer and other thoracic malignancies, including malignant pleural mesothelioma.
The Yale Cancer Center combines innovative cancer treatment with groundbreaking cancer research through a collaboration between the Yale School of Medicine and the Smilow Cancer Hospital. Patients with lung cancer and all types of mesothelioma benefit from Yale’s expertise
The University of Colorado Cancer Center is the premier cancer research and treatment center for the state of Colorado and the Rocky Mountain region. As an NCI-designated comprehensive cancer center, it offers innovative treatment and pursues groundbreaking translational research into all types of cancers, including lung cancer, malignant pleural mesothelioma, and malignant peritoneal mesothelioma.
The University of Southern California Norris Comprehensive Cancer Center was one of the first such facilities to have been designated as a cancer center by the National Cancer Institute. The facility is a leader in cancer research, education, and patient-centered care, and participates in numerous clinical trials focused on improving outcomes for malignant mesothelioma.
The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham is home to a state-of-the-art lung cancer treatment program that treats patients with malignant pleural mesothelioma and an innovative HIPEC treatment program for patients diagnosed with peritoneal mesothelioma. It is the only comprehensive cancer center in the state of Alabama.
The University of California (UC) Davis Comprehensive Cancer Center is the only NCI-Designated Cancer Center located in the Central Valley of Northern California, one of the nation’s premier agricultural regions. The center provides clinical services encompassing all aspects of cancer, including the treatment of malignant mesothelioma and lung cancer through its Thoracic Oncology Program.
Representing a comprehensive approach to world class mesothelioma treatment and innovative research, the Temple Fox-Chase Cancer Center Mesothelioma and Pleural Disease Program is dedicated to the delivery of high quality care for mesothelioma patients. The facility is pursuing innovative research and multiple projects geared towards offering patients improved outcomes and survival.
Consistently ranked in the top two “Best Hospitals for Cancer” every year since U.S. News & World Report began rating hospitals, Memorial Sloan Kettering is a world leader in patient care, research, and educational programs. In keeping with its singular mission of “ending cancer for life,” the hospital has taken a leading role in the treatment of malignant pleural and peritoneal mesothelioma. Its specialists across multiple disciplines work together to develop and demonstrate new approaches to accurate diagnosis and staging, and compassionate, effective treatment of patients with this rare disease.
The Sidney Kimmel Comprehensive Cancer Center is an NCI-recognized comprehensive cancer center and one of the top cancer treatment centers in the country. Part of Johns Hopkins University, the hospital offers a multidisciplinary team approach and treatment options including surgical oncology, chemotherapy, targeted therapy, and immunotherapy. Peritoneal mesothelioma patients treated here can benefit from the Peritoneal Surface Malignancy Program, while those diagnosed with pleural mesothelioma benefit from the Lung Cancer Program.
The Abramson Cancer Center at Penn Medicine in Philadelphia is considered a world leader in patient care and cancer research. Dedicated to offering cancer patients the newest and most innovative therapeutic advances, the center’s focus on “World-Class Cancer Care Here and Now” reflects its goal of improving the detection, diagnosis, and treatment of cancer. Among the innovative specialty areas is the unique Mesothelioma and Pleural Program that offers comprehensive and compassionate care for those suffering from mesothelioma and pleural disease.